University of Pittsburgh Announces 9 U.S. Patents Issued to Pitt Innovators in September 2026
Pitt innovators were issued nine U.S. patents in September 2026. Featured patent: 12,746,528: Hydrogel... Read more
Pitt innovators were issued nine U.S. patents in September 2026. Featured patent: 12,746,528: Hydrogel... Read more
Pitt’s Senior Vice Chancellor for Research, Dr. Rob Rutenbar introduced MIT professor Robert Langer... Read more
Neoolife is pioneering and leading the field of tissue-engineered Biomimetic Heart Valves (BMHV) with polymeric scaffolds enabling endogenous in-situ tissue regeneration. Neoolife will replace mechanical and animal-derived tissue valves with tissue-engineered Biomimetic Heart Valves designed to have an extended duration without the need for blood-thinning drugs. Neoolife tissue-engineered Biomimetic Heart Valves provide a technological solution to the clinicians’ demands of enlarging the pool of patients that can benefit from Transcatheter Heart Valve Therapy.
University of Pittsburgh
Powered by AI. Please verify important information.